About IDRM
The IDRM’s mission is to pioneer new drugs and therapeutic strategies to combat chronic illnesses.
The Institute of Developmental and Regenerative Medicine (IDRM) is a unique flagship institution, at the University of Oxford, dedicated to meeting an ambitious challenge: two thirds of all deaths world-wide are due to non-communicable diseases, many of which are cardiovascular, neurological or immune system disorders that have a developmental origin, representing an urgent unmet clinical need.
Two thirds of world-wide deaths result from noncommunicable diseases
At the heart of the IDRM is a formal integration of developmental biology and regenerative medicine, bringing together world-leading research groups and over 240 scientists working across cardiovascular science, neuroscience, and immunology. This multidisciplinary environment fosters collaboration and innovation at the intersection of biology, medicine, and technology.
To achieve its goals, the IDRM leverages cutting-edge approaches in experimental and computational biology, including machine learning, artificial intelligence, and mathematical modelling. It works closely with University colleagues in Big Data, Target Discovery, Mathematics, and Biomedical Engineering, as well as clinicians at the John Radcliffe and Churchill Hospitals in Oxford.
The Institute of Developmental and Regenerative Medicine (IDRM) brings together researchers from two core departments—the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Paediatrics—while also hosting a number of partner research groups.
The British Heart Foundation Cardiovascular Research floor is home to DPAG and Paediatrics researchers working across eight core groups focused on cardiovascular science. Meanwhile, Paediatrics researchers lead four neuroscience groups and one immunology group, located across two additional floors of the Institute. Collectively, these teams form the backbone of the IDRM’s collaborative and translational research environment.
